T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Essential Utilities
WTRG
$11.3B
| $13.2M | ﹤0.01% |
325,044
-227,345
| -41% | -$10.7M |
|
1177
Advance Auto Parts
AAP
$3.23B
| $13.2M | ﹤0.01% |
140,923
+11,146
| +9% | +$1.44M |
|
|
JNPR
1178
DELISTED
Juniper Networks
JNPR
| $13.1M | ﹤0.01% |
686,258
-1,224,590
| -64% | -$27.5M |
|
1179
Assured Guaranty
AGO
$3.29B
| $13.1M | ﹤0.01% |
507,992
-84,640
| -14% | -$3.5M |
|
1180
Kratos Defense & Security Solutions
KTOS
$11.8B
| $13.1M | ﹤0.01% |
945,658
+345,503
| +58% | +$5.96M |
|
1181
iShares Core MSCI EAFE ETF
IEFA
$196B
| $13M | ﹤0.01% |
261,463
+170,594
| +188% | +$10.2M |
|
1182
OneSpaWorld
OSW
$2.73B
| $13M | ﹤0.01% |
3,201,062
+447,285
| +16% | +$5.38M |
|
1183
LKQ Corp
LKQ
$6.25B
| $13M | ﹤0.01% |
631,492
+44,846
| +8% | +$1.33M |
|
1184
H.B. Fuller
FUL
$3.24B
| $12.9M | ﹤0.01% |
463,036
+2,029
| +0.4% | +$85.2K |
|
1185
F5
FFIV
$24B
| $12.9M | ﹤0.01% |
121,082
+9,368
| +8% | +$1.15M |
|
1186
IPG Photonics
IPGP
$3.71B
| $12.9M | ﹤0.01% |
116,972
-922
| -0.8% | -$121K |
|
1187
Vistra
VST
$49.1B
| $12.7M | ﹤0.01% |
797,612
-32,351
| -4% | -$658K |
|
1188
Howmet Aerospace
HWM
$112B
| $12.7M | ﹤0.01% |
1,028,540
+91,161
| +10% | +$1.9M |
|
1189
Eastman Chemical
EMN
$8.29B
| $12.6M | ﹤0.01% |
271,469
-3,005,553
| -92% | -$193M |
|
1190
Enpro
NPO
$7.12B
| $12.5M | ﹤0.01% |
316,206
-999
| -0.3% | -$55.1K |
|
1191
Health Catalyst
HCAT
$132M
| $12.4M | ﹤0.01% |
475,274
+194,037
| +69% | +$5.93M |
|
1192
Ironwood Pharmaceuticals
IRWD
$714M
| $12.4M | ﹤0.01% |
1,226,123
+59,308
| +5% | +$697K |
|
1193
Supernus Pharmaceuticals
SUPN
$2.78B
| $12.4M | ﹤0.01% |
687,319
-91,977
| -12% | -$1.93M |
|
|
SPNS
1194
DELISTED
Sapiens International
SPNS
| $12.3M | ﹤0.01% |
644,724
+290,130
| +82% | +$6.61M |
|
1195
Jones Lang LaSalle
JLL
$17B
| $12.1M | ﹤0.01% |
119,378
-7,477
| -6% | -$1.12M |
|
|
PFHD
1196
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $12M | ﹤0.01% |
+755,275
| New | +$13.5M |
|
|
RDFN
1197
DELISTED
Redfin
RDFN
| $12M | ﹤0.01% |
776,401
-194,972
| -20% | -$4.54M |
|
|
MIK
1198
DELISTED
Michaels Stores, Inc
MIK
| $11.9M | ﹤0.01% |
7,376,076
+405,545
| +6% | +$1.92M |
|
1199
Theravance Biopharma
TBPH
$878M
| $11.9M | ﹤0.01% |
514,469
-11,969
| -2% | -$300K |
|
1200
PTC
PTC
$16.1B
| $11.9M | ﹤0.01% |
193,883
-48,482
| -20% | -$3.59M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.